269 related articles for article (PubMed ID: 6428981)
21. Inhibition of pentagastrin-stimulated and overnight gastric secretion by LM24056, a new phenothiazine-derived antisecretory drug.
Boyd EJ; Wormsley KG
Lancet; 1981 Feb; 1(8218):471-3. PubMed ID: 6110093
[TBL] [Abstract][Full Text] [Related]
22. Reduction of gastric acid secretion by 10 mg and 30 mg omeprazole once daily.
Nielsen AM; Stenderup J; Wandall JH; Bonnevie O
Scand J Gastroenterol; 1985 Dec; 20(10):1236-8. PubMed ID: 3912960
[TBL] [Abstract][Full Text] [Related]
23. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
Müller P; Seitz HK; Simon B; Dammann HG
Arzneimittelforschung; 1983; 33(12):1685-6. PubMed ID: 6686775
[TBL] [Abstract][Full Text] [Related]
24. Human gastric acid secretion following repeated doses of AG-1749.
Müller P; Dammann HG; Leucht U; Simon B
Aliment Pharmacol Ther; 1989 Apr; 3(2):193-8. PubMed ID: 2491469
[TBL] [Abstract][Full Text] [Related]
25. Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.
Metz DC; Ferron GM; Paul J; Turner MB; Soffer E; Pisegna JR; Bochenek WJ
J Clin Pharmacol; 2002 May; 42(5):512-9. PubMed ID: 12017345
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
Pisegna JR; Martin P; McKeand W; Ohning G; Walsh JH; Paul J
Am J Gastroenterol; 1999 Oct; 94(10):2874-80. PubMed ID: 10520836
[TBL] [Abstract][Full Text] [Related]
27. Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.
Hetzel DJ; Shearman DJ
Br J Clin Pharmacol; 1984 Oct; 18(4):587-90. PubMed ID: 6487498
[TBL] [Abstract][Full Text] [Related]
28. Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action.
Festen HP; Tuynman HA; Den Hollander W; Meuwissen SG
Aliment Pharmacol Ther; 1989 Aug; 3(4):375-9. PubMed ID: 2518851
[TBL] [Abstract][Full Text] [Related]
29. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
Demol P; Singer MV; Dammann HG; Richardson CT; Weihrauch TR
Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
[TBL] [Abstract][Full Text] [Related]
30. Pepsin secretion: neurohumoral regulation and drug effects.
Fimmel CJ; Blum AL
Scand J Gastroenterol Suppl; 1984; 101():39-46. PubMed ID: 6100625
[TBL] [Abstract][Full Text] [Related]
31. Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man.
Thjodleifsson B; Wormsley KG
Gut; 1975 Jul; 16(7):501-8. PubMed ID: 1098968
[TBL] [Abstract][Full Text] [Related]
32. Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B; Müller P; Bliesath H; Lühmann R; Hartmann M; Huber R; Wurst W
Aliment Pharmacol Ther; 1990 Jun; 4(3):239-45. PubMed ID: 1966542
[TBL] [Abstract][Full Text] [Related]
33. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
[TBL] [Abstract][Full Text] [Related]
35. Rabeprazole is superior to omeprazole for the inhibition of peptone meal-stimulated gastric acid secretion in Helicobacter pylori-negative subjects.
Ohning GV; Walsh JH; Pisegna JR; Murthy A; Barth J; Kovacs TO
Aliment Pharmacol Ther; 2003 May; 17(9):1109-14. PubMed ID: 12752347
[TBL] [Abstract][Full Text] [Related]
36. Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Simon B; Müller P; Marinis E; Lühmann R; Huber R; Hartmann R; Wurst W
Aliment Pharmacol Ther; 1990 Aug; 4(4):373-9. PubMed ID: 2151747
[TBL] [Abstract][Full Text] [Related]
37. Effect of pirenzepine on basal gastric acid and pepsin secretion and on secretion stimulated with graded doses of pentagastrin in duodenal ulcer patients.
Meneghelli UG; Troncon LE
Braz J Med Biol Res; 1988; 21(4):781-9. PubMed ID: 3149202
[TBL] [Abstract][Full Text] [Related]
38. Effect of intermittent weekend therapy with omeprazole on basal and bombesin- and pentagastrin-stimulated gastric acid and serum gastrin.
Crobach LF; Jansen JB; Lamers CB
Scand J Gastroenterol; 1988 May; 23(4):407-12. PubMed ID: 3381063
[TBL] [Abstract][Full Text] [Related]
39. Gastric acid and pepsin secretion after single oral doses of mifentidine in healthy subjects.
Lazzaroni M; Imbimbo BP; Sangaletti O; Bianchi Porro G
Scand J Gastroenterol; 1988 Sep; 23(7):788-92. PubMed ID: 2906453
[TBL] [Abstract][Full Text] [Related]
40. Action of mifentidine on the secretory response to sham feeding and pentagastrin and on serum gastrin in duodenal ulcer patients.
Bianchi Porro G; Lazzaroni M; Imbimbo BP; Sangaletti O; Ghirardosi C; Daniotti S
Eur J Clin Pharmacol; 1987; 32(6):555-8. PubMed ID: 2888658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
